Revvity | Der Umsatz



Sales Veränderung Datum
Adcock Ingram Holdings ZAR 4.9B 162.28M 2024-06
Agilent USD 1.68B 20M 2025-01
Align Technology USD 995.22M 17.35M 2024-12
Bio Techne USD 297.03M 7.57M 2024-12
Bio-Rad Laboratories USD 667.5M 17.8M 2024-12
Bruker USD 979.6M 115.2M 2024-12
Celltrion KRW 1.06T 181.72B 2024-12
Charles River Laboratories USD 1B 7.21M 2024-12
Cspc Pharmaceutical CNY 6.32B 78.77M 2024-12
Danaher USD 5.74B 800M 2025-03
Dentsply International USD 905M 46M 2024-12
Dianthus Therapeutics USD 1.33M 846K 2024-12
Ecofibre AUD 7.63M 1.27M 2024-06
Edwards Lifesciences USD 1.41B 24.2M 2025-03
Exact Sciences USD 713.42M 4.77M 2024-12
Hologic USD 1.02B 33.9M 2024-12
Illumina USD 1.1B 24M 2024-12
Intuitive Surgical USD 2.25B 160M 2025-03
IQVIA Holdings USD 3.96B 62M 2024-12
Kangmei Pharma CNY 1.4B 126.12M 2024-09
Knight Therapeutics CAD 92.26M 3.31M 2024-09
Laboratorios Farma 434.41M 256.25M 2024-12
Laboratory Of America USD 3.33B 47.4M 2024-12
Malin Corporation EUR 19.2M 2.6M 2020-12
Medical Developments International AUD 7.54M 0 2023-12
Mettler Toledo International USD 1.05B 95.46M 2024-12
Myriad Genetics USD 210.6M 2.7M 2024-12
Neuren Pharmaceuticals AUD 194.1M 163.93M 2024-12
Organigram Holdings CAD 42.73M 1.97M 2024-12
Pharma Mar EUR 48.36M 2.71M 2024-12
Qiagen NV USD 499.93M 32.58M 2024-12
Quest Diagnostics USD 2.65B 30M 2025-03
Quidel USD 707.8M 19.3M 2024-12
Repligen USD 168M 13M 2024-12
Revvity USD 729.37M 45.32M 2024-12
Sartorius EUR 883M 24M 2025-03
Sino Biopharmaceutical CNY 15.87B 592.96M 2024-06
Thermo Fisher Scientific USD 10.36B 1.04B 2025-03
Tilray USD 264.23M 53.28M 2025-03
Waters USD 872.71M 132.41M 2024-12
Zhangzhou Pientzehuang Pharmaceutical 2.8B 320M 2024-09



Revvity Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.